Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| quant ESG Integration Strategy Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Direct | Direct |
| Fund house | quant | HDFC |
| NAV | ₹42.5037 | ₹23.5160 |
| NAV date | 19 Nov 2026 | 19 Nov 2026 |
| History | 6.0 years | 3.1 years |
| Expense ratio | 1.8% | 1.1% |
| Stars | ★★★★★ | ★★★★★ |
| Growth Score | 56.40 | 94.40 |
Returns
| quant ESG Integration Strategy Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| 1 month | +1.94% | +12.22% |
| 3 months | +0.08% | +6.35% |
| 6 months | +9.97% | +17.38% |
| YTD | +17.20% | +32.83% |
| 1 year | +15.81% | +31.59% |
| 3 years (CAGR) | +16.62% | +30.55% |
| 5 years (CAGR) | +17.13% | — |
| 10 years (CAGR) | — | — |
| Since launch | +27.00% | +31.58% |
Risk
| quant ESG Integration Strategy Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Volatility | 20.7% | 15.7% |
| Downside volatility | 12.8% | 8.5% |
| Sharpe | 0.49 | 1.53 |
| Sortino | 0.79 | 2.85 |
| Calmar | 0.66 | 2.05 |
| Return / risk | 0.80 | 1.95 |
| Deepest fall | −25.06% | −14.91% |
| Days to recover | 449 | 126 |
| Below its high | −2.49% | −0.19% |
Against benchmark
| quant ESG Integration Strategy Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Alpha | — | +7.36% |
| Beta | — | 0.97 |
| R² | — | 85.3% |
| Up capture | — | 108.3% |
| Down capture | — | 71.0% |
| Tracking error | — | 6.0% |
| Information ratio | — | 1.15 |
| Treynor | — | 0.24 |
Consistency
| quant ESG Integration Strategy Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Best 1-year | +91.52% | +67.01% |
| Middle 1-year | +18.79% | +23.22% |
| Worst 1-year | −16.00% | +1.71% |
| 1-year periods with a loss | 12.9% | 0.0% |
| Middle 3-year | +20.68% | +30.17% |
| Positive months | 58.3% | 72.2% |
| Best day | +4.87% | +3.18% |
| Worst day | −5.59% | −3.61% |
| Worst 5% day | −1.74% | −1.51% |
| Positive days | 56.1% | 58.3% |
| NAVs a year | 247 | 247 |
SIP of ₹10,000 a month
| quant ESG Integration Strategy Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| 5-year XIRR | +16.57% | — |
| 5-year value | ₹9,14,836 | — |
| 3-year XIRR | +12.86% | +27.28% |
| 1-year XIRR | +22.13% | +40.05% |
Holdings overlap i
Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.